메뉴 건너뛰기




Volumn 28, Issue 3, 2003, Pages 187-190

Average bioequivalence study of clarithromycin tablets in healthy male volunteers

Author keywords

Bioequivalence; Clarithromycin; Electrochemical detection; Pharmacokinetics

Indexed keywords

CLARITHROMYCIN; FASCAR;

EID: 0038480049     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2003.00479.x     Document Type: Article
Times cited : (7)

References (9)
  • 1
    • 0030943076 scopus 로고    scopus 로고
    • Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients
    • Langtry HD, Brogden RN (1997) Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients. Drugs, 53, 973-1004.
    • (1997) Drugs , vol.53 , pp. 973-1004
    • Langtry, H.D.1    Brogden, R.N.2
  • 2
    • 0034001354 scopus 로고    scopus 로고
    • Clarithromycin in the management of community-acquired pneumonia
    • McCarty JM (2000) Clarithromycin in the management of community-acquired pneumonia. Clinical Therapeutics, 22, 281-294.
    • (2000) Clinical Therapeutics , vol.22 , pp. 281-294
    • McCarty, J.M.1
  • 3
    • 0033022048 scopus 로고    scopus 로고
    • The macrolides: Erythromycin, clarithromycin, and azithromycin
    • Alvarez-Elcoro S, Enzler MJ (1999) The macrolides: erythromycin, clarithromycin, and azithromycin. Mayo Clinic Proceeding, 74, 613-634.
    • (1999) Mayo Clinic Proceeding , vol.74 , pp. 613-634
    • Alvarez-Elcoro, S.1    Enzler, M.J.2
  • 4
    • 0032894333 scopus 로고    scopus 로고
    • The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data
    • Carbon C, Poole MD (1999) The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data. Journal of Chemotherapy, 11, 107-118.
    • (1999) Journal of Chemotherapy , vol.11 , pp. 107-118
    • Carbon, C.1    Poole, M.D.2
  • 5
    • 0032737529 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of clarithromycin
    • Rodvold KA (1999) Clinical pharmacokinetics of clarithromycin. Clinical Pharmacokinetics, 37, 365-398.
    • (1999) Clinical Pharmacokinetics , vol.37 , pp. 365-398
    • Rodvold, K.A.1
  • 7
    • 0027237646 scopus 로고
    • Single- and multiple-dose pharmacokinetics of clarithromycin, a new macrolide antimicrobial
    • Chu SY, Wilson DS, Deaton RL et al. (1993) Single- and multiple-dose pharmacokinetics of clarithromycin, a new macrolide antimicrobial. Journal of Clinical Pharmacology, 33, 719-726.
    • (1993) Journal of Clinical Pharmacology , vol.33 , pp. 719-726
    • Chu, S.Y.1    Wilson, D.S.2    Deaton, R.L.3
  • 8
    • 0026077670 scopus 로고
    • Simultaneous determination of clarithromycin and (14R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection
    • Chu SY, Sennello LT, Sonders RC (1991) Simultaneous determination of clarithromycin and (14R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection. Journal of Chromatography, 571, 199-208.
    • (1991) Journal of Chromatography , vol.571 , pp. 199-208
    • Chu, S.Y.1    Sennello, L.T.2    Sonders, R.C.3
  • 9
    • 0004221461 scopus 로고
    • Rockville, MD: Bioequivalence Food and Drug Administration, Division of Bioequivalence, Office of Generic Drugs 1 July
    • FDA (1992) FDA Guidelines. Rockville, MD: Bioequivalence Food and Drug Administration, Division of Bioequivalence, Office of Generic Drugs 1 July.
    • (1992) FDA Guidelines


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.